The CDMO has enlarged its portfolio from early stage through commercial manufacturing
Ravensburg, Germany, June 18, 2012 / B3C newswire / – The demand for prefilled syringes is on the rise and Vetter is prepared. The company, a leading contract development and manufacturing organization is building a state-of-the-art, high-performance filling line for syringes at its Ravensburg Vetter South location. The line can handle batches of up to 1 million units per day and is particularly well suited for the aseptic filling of high-volume products, like vaccines. The company is also expanding its services for the early clinical phases of new drugs. At its Vetter Development Service locations in Chicago, Illinois (USA), and Ravensburg (Germany), the company offers a wide range of services including formulation support and customized packaging development. With another new filling line at the Ravensburg facility and further investments planned in Chicago, Vetter continues to increase its capabilities in clinical manufacturing.
Vetter is reinforcing its position as a strategic partner for the development and commercial manufacturing of parenteral drugs. With the expansion in capacity and service portfolio, Vetter is providing efficient answers to the growing demand for prefilled syringes throughout a product lifecycle. Vetter Development Service supports customers in efficiently transferring new drugs from early stage phase to commercial manufacturing including regulatory support. The company’s comprehensive know-how in process- and packaging development in aseptic filling is used to support a high-professional clinical offering.
“Vetter is continuously and strategically investing in its partnerships with international customers,” says Peter Soelkner, Vetter Managing Director. “In the area of prefilled syringes we provide our partners a full range of service, from small batches manufacturing and support in early clinical stages to high-volume manufacturing for large scale commercial production.”
Vetter will be at the BIO 2012 in the Boston Convention & Exhibition Center, booth 1825
Vetter is an international contract development and manufacturing organization (CDMO) specializing in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with a broad array of compounds, including monoclonal antibodies, peptides, interferons and vaccines. An independent firm headquartered in Ravensburg, Germany, Vetter provides support for pharmaceutical and biotech clients from preclinical development through regulatory approval and global market supply. Vetter’s new Chicago facility, an expansion of Vetter Development Service, supports early-stage products. The CDMO works with the world’s top 10 pharmaceutical/biotech firms and emerging companies alike, and employs approximately 2,800 staff across Europe and the United States. The innovator of the Vetter Lyo-Ject® dual-chamber syringe and V-LK® cartridge, the company holds numerous patents and is a leader in the use of RABS technology in cleanrooms. Approved as a foreign manufacturer by the government of Japan, Vetter’s global regulatory experience includes numerous customer product approvals by the FDA, EMA and other authorities. Over its more than 25-year history in aseptic filling, Vetter has won many awards for its facilities and operations, including Frost & Sullivan’s 2011 European Prefilled Injection Systems Customer Service Leadership Award.
Vetter Pharma International GmbH
Phone: +49 (0)751-3700-3023
Fax: +49 (0)751-3700-7707